Medpace Holdings MEDP
NASDAQ MEDP
$615.11 -1.33 (-0.22%)
As of: Sep 17, 2026 · 3:59 PM EDT

Medpace Holdings (MEDP) Revenue (2015 - 2026)

Medpace Holdings' (MEDP) quarterly Revenue came in at $707.3 million in Q2 2026, up 17.24% on a YoY basis from $603.3 million in Q2 2025, and little changed quarter-over-quarter from $706.6 million in Q1 2026.

Analysis

Medpace Holdings (MEDP) Revenue (2015 - 2026) Analysis & Trends

Medpace Holdings (MEDP) has reported Revenue for 12 consecutive years, with $707.3 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Revenue rose 17.24% year-over-year to $707.3 million; the trailing twelve-month figure through Jun 2026 stood at $2.8 billion (up 24.67% YoY), and the FY2025 full-year result was $2.5 billion, up 19.97% from the prior year.
  • Revenue held at $707.3 million in Q2 2026 per MEDP's latest filing, from $706.6 million in the prior quarter.
  • Across five years, Revenue topped out at $708.4 million in Q4 2025 and bottomed at $330.9 million in Q1 2022.
  • Historically, Revenue has averaged $522.2 million across 5 years, with a median of $519.6 million in 2024.
  • The sharpest annual moves came in 2024 and 2025: Revenue advanced 7.66% in 2024, then soared 32.03% in 2025.
  • Over 5 years, Revenue stood at $394.1 million in 2022, then gained by 26.47% to $498.4 million in 2023, then rose by 7.66% to $536.6 million in 2024, then jumped by 32.03% to $708.4 million in 2025, then slipped by 0.16% to $707.3 million in 2026.
  • According to Business Quant data, Revenue over the past three periods registered $707.3 million, $706.6 million, and $708.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Iqvia Holdings 44.72 Bn 42.64 Bn 1.44 Bn 4.37 Bn
2 Medpace Holdings 17.37 Bn 16.87 Bn 201.64 Mn 707.33 Mn
3 Icon 13.65 Bn 12.72 Bn 479.29 Mn 2.06 Bn
4 Charles River Laboratories International 13.13 Bn 12.94 Bn 452.07 Mn 1.00 Bn
5 Fortrea Holdings 1.89 Bn 1.72 Bn 139.20 Mn 678.20 Mn
6 Evotec SE 574.75 Mn 148.87 Mn - -
7 Ginkgo Bioworks Holdings 439.63 Mn 355.09 Mn 18.44 Mn 20.16 Mn
8 Champions Oncology 69.43 Mn 65.03 Mn 7.70 Mn 15.23 Mn
9 MindWalk Holdings 51.76 Mn 46.29 Mn 1.61 Mn 2.75 Mn
10 VivoSim Labs 1.37 Mn 1.37 Mn - 18,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 707.33 Mn
Mar 31, 2026 706.60 Mn
Dec 31, 2025 708.45 Mn
Sep 30, 2025 659.90 Mn
Jun 30, 2025 603.31 Mn
Mar 31, 2025 558.57 Mn
Dec 31, 2024 536.59 Mn
Sep 30, 2024 533.32 Mn
Jun 30, 2024 528.10 Mn
Mar 31, 2024 511.04 Mn
Dec 31, 2023 498.40 Mn
Sep 30, 2023 492.50 Mn
Jun 30, 2023 460.87 Mn
Mar 31, 2023 434.07 Mn
Dec 31, 2022 394.10 Mn
Sep 30, 2022 383.74 Mn
Jun 30, 2022 351.21 Mn
Mar 31, 2022 330.95 Mn
Dec 31, 2021 308.55 Mn
Sep 30, 2021 295.57 Mn